»N2B-Patch« – Nose-To-Brain Delivery of an Active Pharmaceutical Ingredient via the Olfactory Region by Carmen Gruber Traub* and Jenny Ullrich in Drug Designing & Intellectual Properties International Journal (DDIPIJ) in Lupine Publishers
Within the EU funded project »N2B-patch« eleven partners from eight countries aim to develop an innovative technology for the nose-to-brain delivery of an active pharmaceutical ingredient via the olfactory region for the regenerative treatment of multiple sclerosis using novel multi-functional biomaterials combined with a medical device. The four year EU-funded research involves an innovative method of bypassing the blood-brain barrier by delivering a potential multiple sclerosis drug with a special medical device via the nose directly to the brain.
http://www.lupinepublishers.com/ddipij/abstracts/DDIPIJ.MS.ID.000116.php
http://www.lupinepublishers.com/ddipij/fulltext/DDIPIJ.MS.ID.000116.php
http://www.lupinepublishers.com/ddipij/pdf/DDIPIJ.MS.ID.000116.pdf
Within the EU funded project »N2B-patch« eleven partners from eight countries aim to develop an innovative technology for the nose-to-brain delivery of an active pharmaceutical ingredient via the olfactory region for the regenerative treatment of multiple sclerosis using novel multi-functional biomaterials combined with a medical device. The four year EU-funded research involves an innovative method of bypassing the blood-brain barrier by delivering a potential multiple sclerosis drug with a special medical device via the nose directly to the brain.
http://www.lupinepublishers.com/ddipij/abstracts/DDIPIJ.MS.ID.000116.php
http://www.lupinepublishers.com/ddipij/fulltext/DDIPIJ.MS.ID.000116.php
http://www.lupinepublishers.com/ddipij/pdf/DDIPIJ.MS.ID.000116.pdf

No comments:
Post a Comment
Note: only a member of this blog may post a comment.